TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 35997144

Group type: EXPERIMENTAL
Intervention: Continuous non-invasive arterial pressure (CNAP)
Number of subjects: 106

Group type: COMPARATOR
Intervention: Non-invasive blood pressure (NIBP)
Number of subjects: 106

Group type: EXPERIMENTAL
Intervention: CNAP
Number of subjects: 106
Study: 34226708

Group type: EXPERIMENTAL
Intervention: Healthy choice intervention using a dietary prime
Number of subjects: 0
Study: 32396179

Group type: EXPERIMENTAL
Intervention: Surgical treatment with open reduction and internal plate fixation (n=38)
Number of subjects: 82

Group type: COMPARATOR
Intervention: Nonsurgical treatment with functional bracing (n=44)
Number of subjects: 82
Study: 37436828

Group type: EXPERIMENTAL
Intervention: Tocilizumab 162 mg weekly
Number of subjects: 20

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Continuous-tocilizumab
Number of subjects: 20

Group type: COMPARATOR
Intervention: Placebo-tocilizumab
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Tocilizumab
Number of subjects: 20
Study: 33323787

Group type: EXPERIMENTAL
Intervention: Neostigmine
Number of subjects: 200

Group type: COMPARATOR
Intervention: Sugammadex
Number of subjects: 200
Study: 32371711

Group type: EXPERIMENTAL
Intervention: Conventional Endoscopic Sinus Surgery (ESS)
Number of subjects: 44

Group type: COMPARATOR
Intervention: Balloon Sinuplasty
Number of subjects: 44
Study: 36104702

Group type: EXPERIMENTAL
Intervention: Vaporized nicotine products (VNPs) - pod (40 mg/mL nicotine salt) and tank device (18 mg/mL freebase nicotine)
Number of subjects: 1058

Group type: COMPARATOR
Intervention: Nicotine replacement therapy (NRT) - gum or lozenge (4 mg)
Number of subjects: 1058
Study: 33099189

Group type: EXPERIMENTAL
Intervention: Influencer-high group (idealised imagery alongside high 'like'/follow metrics)
Number of subjects: 111

Group type: EXPERIMENTAL
Intervention: Influencer-low group (idealised imagery adjusted for low popularity metrics)
Number of subjects: 111

Group type: COMPARATOR
Intervention: Nature control group with matched low‐popularity metrics
Number of subjects: 111
Study: 33224416

Group type: EXPERIMENTAL
Intervention: Ibuprofen (10mg/kg)
Number of subjects: 140

Group type: COMPARATOR
Intervention: Paracetamol (15mg/kg)
Number of subjects: 140
Study: 35988360

Group type: EXPERIMENTAL
Intervention: CIPRO+FLUO (ciprofloxacin 0.3 % and fluocinolone acetonide 0.025 % otic solution)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: CIPRO (ciprofloxacin 0.3 % otic solution)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: FLUO (fluocinolone acetonide 0.025 % otic solution)
Number of subjects: 30
Study: 32687890

Group type: EXPERIMENTAL
Intervention: Ultrasound guidance during IUD insertion
Number of subjects: 400
Study: 34593706

Group type: EXPERIMENTAL
Intervention: Airway Pressure Release Ventilation
Number of subjects: 90

Group type: COMPARATOR
Intervention: Low Tidal Volume Ventilation
Number of subjects: 90
Study: 33247625

Group type: EXPERIMENTAL
Intervention: Vidian Neurectomy (VN)
Number of subjects: 21

Group type: COMPARATOR
Intervention: Control Eye (no intervention)
Number of subjects: 21
Study: 35177042

Group type: EXPERIMENTAL
Intervention: Multi-faceted intervention including patient education brochure and personalized letter with Bruyere's PPI deprescribing algorithm sent to GPs.
Number of subjects: 33000

Group type: COMPARATOR
Intervention: Single intervention where only GPs received the letter and algorithm.
Number of subjects: 33000

Group type: COMPARATOR
Intervention: No intervention (control arm).
Number of subjects: 33000

Group type: EXPERIMENTAL
Intervention: Multi-faceted intervention
Number of subjects: 33000

Group type: EXPERIMENTAL
Intervention: Incremental cost-utility ratio using EQ-5D-5L scale.
Number of subjects: 33000

Group type: EXPERIMENTAL
Intervention: Acid rebound measured using the Gastroesophageal Reflux Disease Impact Scale.
Number of subjects: 33000

Group type: EXPERIMENTAL
Intervention: Patients' attitudes towards deprescribing measured using the French rPATD.
Number of subjects: 33000
Study: 34939004

Group type: EXPERIMENTAL
Intervention: Exercise is Medicine (EIM) intervention framework (mHealth components plus twice‐weekly small‐group directed exercise sessions)
Number of subjects: 56

Group type: COMPARATOR
Intervention: Mobile health (mHealth) group (wearable activity trackers and fitness professional counseling)
Number of subjects: 56
Study: 35717241

Group type: EXPERIMENTAL
Intervention: Clarithromycin (1 gr intravenously once daily for 4 days)
Number of subjects: 110

Group type: COMPARATOR
Intervention: Placebo (intravenously once daily for 4 days)
Number of subjects: 110

Group type: EXPERIMENTAL
Intervention: Clarithromycin
Number of subjects: 110

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 110
Study: 33120640

Group type: EXPERIMENTAL
Intervention: Mohindra's near retinoscopy (MNR)
Number of subjects: 101

Group type: COMPARATOR
Intervention: Post cycloplegic refraction (PCRef)
Number of subjects: 101

Group type: EXPERIMENTAL
Intervention: Correlation analysis
Number of subjects: 101

Group type: EXPERIMENTAL
Intervention: Agreement analysis
Number of subjects: 101

Group type: EXPERIMENTAL
Intervention: Regression analysis
Number of subjects: 101
Study: 32299251

Group type: EXPERIMENTAL
Intervention: Aminophylline treatment
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 33752164

Group type: EXPERIMENTAL
Intervention: sprifermin 100 µg every 6 months (q6mo)
Number of subjects: 161

Group type: COMPARATOR
Intervention: placebo
Number of subjects: 161
Study: 34874523

Group type: EXPERIMENTAL
Intervention: Interactive Dynamic Scalp Acupuncture (IDSA)
Number of subjects: 660

Group type: COMPARATOR
Intervention: Simple Combination Therapy (SCT)
Number of subjects: 660

Group type: COMPARATOR
Intervention: Traditional Scalp Acupuncture (TSA)
Number of subjects: 660
Study: 32514040

Group type: EXPERIMENTAL
Intervention: Intranasal administration of oxytocin (OT) in the minimal social contact (MSC) condition
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Intranasal administration of oxytocin (OT) in the no-social-contact (NoC) condition
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo in the minimal social contact (MSC) condition
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo in the no-social-contact (NoC) condition
Number of subjects: 0
Study: 36280407

Group type: EXPERIMENTAL
Intervention: NRD assisted Ilizarov technique
Number of subjects: 48

Group type: COMPARATOR
Intervention: Traditional bone transport technique
Number of subjects: 48
Study: 34342585

Group type: EXPERIMENTAL
Intervention: Ecological momentary assessment (EMA) intervention across 30 days
Number of subjects: 952

Group type: EXPERIMENTAL
Intervention: Event-contingent prompts after engaging in substance use
Number of subjects: 952

Group type: EXPERIMENTAL
Intervention: EMA interventions focusing on psychological and behavioral outcomes
Number of subjects: 952
Study: 35019769

Group type: EXPERIMENTAL
Intervention: Listerine mouthwash
Number of subjects: 153

Group type: EXPERIMENTAL
Intervention: Biotène dry mouth oral rinse
Number of subjects: 153
Study: 33001229

Group type: EXPERIMENTAL
Intervention: MASK (flow‐resistive mask)
Number of subjects: 23

Group type: EXPERIMENTAL
Intervention: IMT (pressure threshold loading inspiratory muscle training)
Number of subjects: 23

Group type: COMPARATOR
Intervention: CON (HIIT only)
Number of subjects: 23
Study: 32820573

Group type: EXPERIMENTAL
Intervention: Epidemiological agent-based models (ABMs) such as AceMod for the COVID-19 epidemic in Australia
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Epidemiological agent-based models (ABMs)
Number of subjects: 0
Study: 35536364

Group type: EXPERIMENTAL
Intervention: Free fibular graft group (FFG)
Number of subjects: 182

Group type: EXPERIMENTAL
Intervention: Free vascularized fibular graft group (FVFG)
Number of subjects: 182

Group type: EXPERIMENTAL
Intervention: Autologous iliac bone group (ABG)
Number of subjects: 182

Group type: EXPERIMENTAL
Intervention: β-tricalcium bioceramics phosphate graft (β-TCPG)
Number of subjects: 182

Group type: COMPARATOR
Intervention: All groups
Number of subjects: 182
Study: 34265462

Group type: EXPERIMENTAL
Intervention: ChAdOx1 nCoV-19 (1 dose)
Number of subjects: 8165

Group type: EXPERIMENTAL
Intervention: mRNA BNT162b2 (1 dose)
Number of subjects: 8165

Group type: EXPERIMENTAL
Intervention: mRNA BNT162b2 (2 doses)
Number of subjects: 8165

Group type: EXPERIMENTAL
Intervention: mRNA-1273 (1 dose)
Number of subjects: 8165

Group type: EXPERIMENTAL
Intervention: mRNA-1273 (2 doses)
Number of subjects: 8165

Group type: COMPARATOR
Intervention: Non-vaccinated HCWs
Number of subjects: 8165
Study: 33338947

Group type: EXPERIMENTAL
Intervention: Simvastatin plus metformin
Number of subjects: 5

Group type: COMPARATOR
Intervention: Metformin
Number of subjects: 5
Study: 32504574

Group type: EXPERIMENTAL
Intervention: Bictegravir 50 mg, emtricitabine 200 mg, and tenofovir alafenamide 25 mg
Number of subjects: 1274

Group type: COMPARATOR
Intervention: Dolutegravir 50 mg, abacavir 600 mg, and lamivudine 300 mg
Number of subjects: 1274

Group type: COMPARATOR
Intervention: Dolutegravir 50 mg, emtricitabine 200 mg, and tenofovir alafenamide 25 mg
Number of subjects: 1274

Group type: EXPERIMENTAL
Intervention: Bictegravir, emtricitabine, and tenofovir alafenamide
Number of subjects: 1274

Group type: COMPARATOR
Intervention: Dolutegravir, abacavir, and lamivudine
Number of subjects: 1274

Group type: COMPARATOR
Intervention: Dolutegravir, emtricitabine, and tenofovir alafenamide
Number of subjects: 1274
Study: 35987487

Group type: EXPERIMENTAL
Intervention: Trauma-Focused Therapy (TFT) - Prolonged Exposure or Cognitive Processing Therapy
Number of subjects: 420

Group type: COMPARATOR
Intervention: Non-Trauma-Focused Therapy (NTFT) - Present Centered Therapy (PCT)
Number of subjects: 420
Study: 34001622

Group type: EXPERIMENTAL
Intervention: Heightened awareness of immigration detention policies
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Heightened awareness of nonjudicial removals
Number of subjects: 0
Study: 32668990

Group type: EXPERIMENTAL
Intervention: Percutaneous nephrolithotomy (PNL)
Number of subjects: 80

Group type: COMPARATOR
Intervention: Extracorporeal shock wave lithotripsy (SWL)
Number of subjects: 80

Group type: COMPARATOR
Intervention: SWL
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: PNL
Number of subjects: 80
Study: 33522583

Group type: EXPERIMENTAL
Intervention: Motor skills in toddlers with ASD with delayed receptive language (RL) and expressive language (EL) development
Number of subjects: 38

Group type: EXPERIMENTAL
Intervention: Motor skills in toddlers with ASD with typical RL and EL development
Number of subjects: 38

Group type: EXPERIMENTAL
Intervention: Motor skills in toddlers with ASD
Number of subjects: 38

Group type: COMPARATOR
Intervention: Motor skills in toddlers with TD
Number of subjects: 38
Study: 33323432

Group type: EXPERIMENTAL
Intervention: Intravenous propofol
Number of subjects: 80

Group type: COMPARATOR
Intervention: Inhalational desflurane
Number of subjects: 80
Study: 36336284

Group type: EXPERIMENTAL
Intervention: Covered Stents (CS)
Number of subjects: 174

Group type: COMPARATOR
Intervention: Bare Metal Stents (BMS)
Number of subjects: 174
Study: 33078216

Group type: EXPERIMENTAL
Intervention: Active suction (AS) drainage
Number of subjects: 3430

Group type: COMPARATOR
Intervention: Passive gravity (PG) drainage
Number of subjects: 3430
Study: 32059587

Group type: EXPERIMENTAL
Intervention: 90-minute educational intervention on breast cancer screening
Number of subjects: 183

Group type: COMPARATOR
Intervention: Educational materials provided at the end of the study (Control)
Number of subjects: 183

Group type: EXPERIMENTAL
Intervention: Educational intervention
Number of subjects: 183
Study: 35320927

Group type: EXPERIMENTAL
Intervention: ADD (pecans 68 g/d)
Number of subjects: 93

Group type: EXPERIMENTAL
Intervention: SUB (pecans 68 g/d with isocaloric substitution)
Number of subjects: 93

Group type: COMPARATOR
Intervention: Control (nut-free)
Number of subjects: 93
Study: 33527654

Group type: EXPERIMENTAL
Intervention: Ambulatory medication intervention (diuretic up-titration PRN)
Number of subjects: 66
Study: 33226277

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 239

Group type: EXPERIMENTAL
Intervention: 4,200 IU Vitamin D3
Number of subjects: 239

Group type: EXPERIMENTAL
Intervention: 16,800 IU Vitamin D3
Number of subjects: 239

Group type: EXPERIMENTAL
Intervention: 28,000 IU Vitamin D3
Number of subjects: 239
Study: 35361169

Group type: EXPERIMENTAL
Intervention: Needle aspiration of calcific deposits (NACD)
Number of subjects: 140

Group type: COMPARATOR
Intervention: Extracorporeal shock wave therapy (ESWT)
Number of subjects: 140

Group type: EXPERIMENTAL
Intervention: NACD and ESWT
Number of subjects: 140
Study: 34085466

Group type: EXPERIMENTAL
Intervention: Joint administration of acupuncture, western and herbal medicines, and bamboo-jar-cupping (kept for 10 min), treatment conducted once a day for 2 weeks.
Number of subjects: 100

Group type: COMPARATOR
Intervention: Conventional western medicines and Chinese herbal medicines (for anti-platelet aggregation, blood-lipid regulation, arterial plaque-stabilization, cerebral cell protection, blood pressure-lowering, and promoting blood circulation to dredge the meridian-collaterals).
Number of subjects: 100

Group type: COMPARATOR
Intervention: Treatment group (acupuncture + cupping) vs Control group (acupuncture + conventional western and herbal medicines).
Number of subjects: 100
Study: 616505834

Group type: EXPERIMENTAL
Intervention: Fibre-enriched nutrition solution
Number of subjects: 120

Group type: COMPARATOR
Intervention: Fibre-free nutrition solution
Number of subjects: 120
Study: 33955809

Group type: EXPERIMENTAL
Intervention: 15% DTP and 5% DGP
Number of subjects: 72

Group type: COMPARATOR
Intervention: DGP
Number of subjects: 72

Group type: EXPERIMENTAL
Intervention: FSM and DTP
Number of subjects: 72

Group type: EXPERIMENTAL
Intervention: Dietary treatments
Number of subjects: 72
Study: 32853042

Group type: EXPERIMENTAL
Intervention: Lateral epicondylitis (LE) cohort
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control cohort (patients without LE)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Lateral epicondylitis (LE) cohort (aged 50 to 64 years)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Lateral epicondylitis (LE) cohort (aged over 65 years)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Lateral epicondylitis (LE) cohort (women)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Female patients with lateral epicondylitis (LE)
Number of subjects: 0
Study: 33637020

Group type: EXPERIMENTAL
Intervention: Lenvatinib
Number of subjects: 0
Study: 33054003

Group type: EXPERIMENTAL
Intervention: Improved methods of physical training with interval cyclic training on treadmills and sensory tracks, therapeutic exercises in the gym (daily, 5 times a week, for a course of 10 procedures)
Number of subjects: 120

Group type: COMPARATOR
Intervention: Enhanced external counterpulsation, general dry air carbon dioxide, infrared matrix laser therapy
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Complex of physical training and therapeutic procedures for metabolic processes restoration
Number of subjects: 120
Study: 33397443

Group type: EXPERIMENTAL
Intervention: LSI + pioglitazone (PGZ) 15 mg qd
Number of subjects: 185

Group type: COMPARATOR
Intervention: LSI
Number of subjects: 185
Study: 35864578

Group type: EXPERIMENTAL
Intervention: Intralesional 5-fluorouracil/lidocaine/epinephrine (5-FU + LE)
Number of subjects: 45

Group type: COMPARATOR
Intervention: Cryotherapy
Number of subjects: 45
Study: 32410203

Group type: COMPARATOR
Intervention: Kinematic analysis of swallowing mechanics in HNC cohort
Number of subjects: 10

Group type: COMPARATOR
Intervention: Kinematic analysis of swallowing mechanics in stroke cohort
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Multivariate morphometric canonical variate analysis among etiology groups
Number of subjects: 10
Study: 35275567

Group type: EXPERIMENTAL
Intervention: Lateral truncal tilt training with a wedge
Number of subjects: 33

Group type: COMPARATOR
Intervention: Control training
Number of subjects: 33
Study: 34137226

Group type: EXPERIMENTAL
Intervention: MIA orthodontic system
Number of subjects: 40

Group type: COMPARATOR
Intervention: Traditional sliding straight wire appliance (control group)
Number of subjects: 40
Study: 34116824

Group type: EXPERIMENTAL
Intervention: Peer recovery coach support
Number of subjects: 0

Group type: COMPARATOR
Intervention: Standard reentry program (Control)
Number of subjects: 0
Study: 32140811

Group type: EXPERIMENTAL
Intervention: CP-CEF (four 3-week cycles of carboplatin [CBDCA] and weekly paclitaxel [wPTX] followed by four 3-week cycles of cyclophosphamide, epirubicin, and 5-fluorouracil [CEF])
Number of subjects: 179

Group type: COMPARATOR
Intervention: P-CEF (four cycles of wPTX followed by four cycles of CEF)
Number of subjects: 179
Study: 36339436

Group type: EXPERIMENTAL
Intervention: Risk prediction model based on independent risk factors (HbA1c level, 2hCP, age, FFA)
Number of subjects: 3126

Group type: EXPERIMENTAL
Intervention: Validation of the risk prediction model
Number of subjects: 3126
Study: 32447296

Group type: EXPERIMENTAL
Intervention: Durvalumab (1500 mg IV every 4 weeks for 24 cycles) + concurrent chemoradiotherapy
Number of subjects: 714

Group type: COMPARATOR
Intervention: Placebo + concurrent chemoradiotherapy
Number of subjects: 714
Study: 33413493

Group type: EXPERIMENTAL
Intervention: Coaching for Addiction Recovery Enhancement (CARE)
Number of subjects: 2000
Study: 33068342

Group type: EXPERIMENTAL
Intervention: Acupuncture technique of Jingou Diaoyu combined with speech rehabilitation training
Number of subjects: 70

Group type: COMPARATOR
Intervention: Speech rehabilitation training alone (Control group)
Number of subjects: 70
Study: 35177777

Group type: EXPERIMENTAL
Intervention: Oral hydroxyurea 10-20 mg/kg/day
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Hydroxyurea-responders
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Hydroxyurea
Number of subjects: 60
Study: 34670666

Group type: EXPERIMENTAL
Intervention: Tormentic acid (TA) at doses of 35, 25, 15 μmol/L
Number of subjects: 0

Group type: COMPARATOR
Intervention: PDGF-BB (20 ng/mL)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: PDTC (20 ng/mL of PDGF-BB combined with 10 mmol/L of PDTC)
Number of subjects: 0
Study: 32925910

Group type: EXPERIMENTAL
Intervention: G6PD deficiency testing
Number of subjects: 1002

Group type: EXPERIMENTAL
Intervention: G6PD activity measurement
Number of subjects: 1002

Group type: EXPERIMENTAL
Intervention: Malaria status assessment
Number of subjects: 1002
Study: 34591550

Group type: EXPERIMENTAL
Intervention: Family Check-Up (FCU) prevention program
Number of subjects: 2322
Study: 32108254

Group type: EXPERIMENTAL
Intervention: Triphasic calcium sulfate/calcium phosphate implant material injection
Number of subjects: 21

Group type: COMPARATOR
Intervention: Sham group (no implant material injection)
Number of subjects: 21

Group type: COMPARATOR
Intervention: Control group (untreated intact osteoporotic vertebra)
Number of subjects: 21
Study: 35197549

Group type: EXPERIMENTAL
Intervention: Breast milk (BM)
Number of subjects: 0

Group type: COMPARATOR
Intervention: 24% sucrose
Number of subjects: 0
Study: 33578837

Group type: EXPERIMENTAL
Intervention: Nurses' knowledge
Number of subjects: 225

Group type: EXPERIMENTAL
Intervention: Nurses' attitudes
Number of subjects: 225

Group type: EXPERIMENTAL
Intervention: Correlation between knowledge and attitudes
Number of subjects: 225

Group type: EXPERIMENTAL
Intervention: Knowledge differences based on education level
Number of subjects: 225

Group type: EXPERIMENTAL
Intervention: Knowledge differences based on work department
Number of subjects: 225
Study: 35363821

Group type: EXPERIMENTAL
Intervention: Exercise condition (six weeks of resistance and cardiovascular exercises)
Number of subjects: 15

Group type: COMPARATOR
Intervention: Control condition (no exercise)
Number of subjects: 15
Study: 33468164

Group type: EXPERIMENTAL
Intervention: Fecal microbiota transplant (FMT)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Control
Number of subjects: 20
Study: 32416781

Group type: EXPERIMENTAL
Intervention: Nivolumab plus ipilimumab
Number of subjects: 167

Group type: EXPERIMENTAL
Intervention: Nivolumab monotherapy
Number of subjects: 167

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 167
Study: 36201851

Group type: EXPERIMENTAL
Intervention: ShipShape enhanced with acceptance and commitment therapy
Number of subjects: 178

Group type: COMPARATOR
Intervention: ShipShape (in-person)
Number of subjects: 178
Study: 34769920

Group type: EXPERIMENTAL
Intervention: Exposure to multiple types of abuse
Number of subjects: 499

Group type: EXPERIMENTAL
Intervention: Exposure to multiple types of abuse during childhood/early adolescence and again in late adolescence
Number of subjects: 499
Study: 32384010

Group type: EXPERIMENTAL
Intervention: Patients with congenital heart disease (CHD)
Number of subjects: 14433

Group type: COMPARATOR
Intervention: Reference cohort (matched by sex and birth year)
Number of subjects: 14433
Study: 35683447

Group type: EXPERIMENTAL
Intervention: Coenzyme Q10 hydrogel
Number of subjects: 18
Study: 33621337

Group type: COMPARATOR
Intervention: Non-targeted ads from the truth antismoking campaign
Number of subjects: 1161

Group type: EXPERIMENTAL
Intervention: Black-targeted truth ads
Number of subjects: 1161

Group type: EXPERIMENTAL
Intervention: SGM-targeted truth ads
Number of subjects: 1161

Group type: COMPARATOR
Intervention: Unrelated control ads
Number of subjects: 1161
Study: 34180625

Group type: EXPERIMENTAL
Intervention: Botulinum toxin type A (BTX‐A) injection
Number of subjects: 24

Group type: COMPARATOR
Intervention: Surgical lip repositioning
Number of subjects: 24
Study: 35028656

Group type: EXPERIMENTAL
Intervention: mySmartSkin (MSS)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 0
Study: 33667665

Group type: EXPERIMENTAL
Intervention: Cisplatin alone or in combination with pemetrexed
Number of subjects: 441

Group type: EXPERIMENTAL
Intervention: ALL dataset
Number of subjects: 441

Group type: EXPERIMENTAL
Intervention: R1.1 dataset
Number of subjects: 441

Group type: EXPERIMENTAL
Intervention: Reducing the number of target lesions
Number of subjects: 441
Study: 32575868

Group type: EXPERIMENTAL
Intervention: ANFIS model
Number of subjects: 4012

Group type: EXPERIMENTAL
Intervention: FN model
Number of subjects: 4012

Group type: EXPERIMENTAL
Intervention: RF model
Number of subjects: 4012

Group type: EXPERIMENTAL
Intervention: SVM model
Number of subjects: 4012

Group type: COMPARATOR
Intervention: Empirical correlations
Number of subjects: 4012
Study: 35841586

Group type: EXPERIMENTAL
Intervention: Intravenous (IV) administration of danofloxacin at 10 mg/kg
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Intramuscular (IM) administration of danofloxacin at 10 mg/kg
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Subcutaneous (SC) administration of danofloxacin at 10 mg/kg
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Oral (PO) administration of danofloxacin at 10 mg/kg
Number of subjects: 8